Patients with classic citrullinemia (type I) (argininosuccinate synthetase 1 gene mutation) present with elevated citrulline levels along with hyperammonemia and variable neurological symptoms in the neonatal period or later on. This evidence concerns the gene ASS1 and Hyperammonemia.